youtube_live
Q4 2026 earnings
See detailschevron_right
REPL:NASDAQ
Replimune Group Inc
$9.47
arrow_downward
-4.05%(-0.40) 1D
$9.45
arrow_downward
-0.21% (-0.020)bedtimeAfter hours
Closed: Jun 5, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REPL...
Open
$9.98
High
$10.46
Low
$9.39
Mkt. cap
781.96M
Avg. vol.
8.47M
Volume
4.61M
52-wk high
$13.24
52-wk low
$1.50
EPS
-$3.44
Beta
0.91
Shares outstanding
82.57M
No. of employees
479
Open
$9.98
High
$10.46
Low
$9.39
Mkt. cap
781.96M
Avg. vol.
8.47M
Volume
4.61M
52-wk high
$13.24
52-wk low
$1.50
EPS
-$3.44
Beta
0.91
Shares outstanding
82.57M
No. of employees
479
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to REPL in the past 3 months
Hold
Buy
0
Hold
6
Sell
2
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for REPL in the last 3 months.
Highest
Current $9.47
$8.00 (-15.52%)
Average
$4.20 (-55.65%)
Lowest
$1.00 (-89.44%)
News stories
From sources across the web
Seeking Alpha
·
1 day ago
Replimune: Modeling The Coin Flip Of FDA Approval
About Replimune Group Inc
CEO-
Employees479
Founded2015
HeadquartersWoburn, Massachusetts, United States
SectorBiotechnology
Websitereplimune.com
AI content may include mistakes. Learn more